AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce its selection for the prestigious “Forbes Asia 100 to Watch 2024" list.

The “Forbes Asia 100 To Watch” is an annual feature by 

Forbes Asia

 that is now in its fourth edition. The list spotlights small companies and startups across the Asia-Pacific region that are on the rise and attracting the attention of investors. 

The list can be found here and as well as in the September issue of 

Forbes Asia

.

AIM was selected in the biotechnology and healthcare category.

For more details, please see the link below:

https://www.forbes.com/sites/forbesasiateam/2024/08/26/forbes-asia-100-to-watch-2024/